• Join
  • Login
  • Contact

Search abstracts

Analysis of biosimilars: Finding the relevant needles in a haystack

  • At: Basel (Switzerland) (2008)
  • Type: Presentation
  • By: VAN DE WEERT, Marco (University of Copenhagen, Copenhagen, Denmark)
  • Abstract:

    Market approval of most generic medicines requires the generic manufacturer to show bioequivalence to the innovator drug. While a similar approach would be desired for biosimilar proteins, their highly complex behaviour makes this impossible. In particular, the danger of invoking an immune response is a special feature of protein drugs, and this


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses